APA (7th ed.) Citation

Prosz, A., Duan, H., Tisza, V., Sahgal, P., Topka, S., Klus, G. T., . . . Spisak, S. (2023). Nucleotide excision repair deficiency is a targetable therapeutic vulnerability in clear cell renal cell carcinoma. Scientific Reports, 13(1), 1. https://doi.org/10.1038/s41598-023-47946-4

Chicago Style (17th ed.) Citation

Prosz, Aurel, et al. "Nucleotide Excision Repair Deficiency Is a Targetable Therapeutic Vulnerability in Clear Cell Renal Cell Carcinoma." Scientific Reports 13, no. 1 (2023): 1. https://doi.org/10.1038/s41598-023-47946-4.

MLA (9th ed.) Citation

Prosz, Aurel, et al. "Nucleotide Excision Repair Deficiency Is a Targetable Therapeutic Vulnerability in Clear Cell Renal Cell Carcinoma." Scientific Reports, vol. 13, no. 1, 2023, p. 1, https://doi.org/10.1038/s41598-023-47946-4.